Serine

Serine

SCHEMBL9512908

CC[C@H](C)[C@H](N)C(=O)Oc1ccc(C[C@H](N)C(=O)O)cc1.N=C(N)NCCC[C@H](N)C(N)=O.NCC(=O)O.N[C@@H](CO)C(=O)O

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Serine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
NPY4R P50391 15/20 0.40
NPY1R P25929 9/20 0.40
NPY5R Q15761 7/20 0.39
NPY2R P49146 5/20 0.39
SLC7A5 Q01650 1/20 0.36
ITGB3 P05106 1/20 0.35
ITGA2B P08514 1/20 0.35
GRB2 P62993 1/20 0.33
KISS1R Q969F8 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Serine SCHEMBL675717 0.93 NPY4R (0.39) NPY4RNPY1RNPY5RNPY2RSLC7A5
Arginine SCHEMBL6808147 0.90 NPY4R (0.45) NPY4RNPY1RNPY5RNPY2RSLC7A5
Glycine SCHEMBL9511974 0.89 NPY4R (0.40) NPY4RNPY1RNPY5RNPY2RSLC7A5
Serine SCHEMBL15752146 0.89 NPY4R (0.41) NPY4RNPY1RNPY5RNPY2RSLC7A5
Glycine SCHEMBL5344900 0.84 NPY4R (0.38) NPY4RNPY1RNPY5RNPY2RSLC7A5
Serine SCHEMBL9509964 0.84 NPY4R (0.38) NPY4RNPY1RNPY5RNPY2RSLC7A5
Tyrosine SCHEMBL27616071 0.84 NPY4R (0.46) NPY4RNPY1RNPY5RNPY2RSLC7A5
Tyrosine SCHEMBL27510324 0.84 NPY4R (0.46) NPY4RNPY1RNPY5RNPY2RSLC7A5
Aspartic Acid SCHEMBL10457651 0.84 SLC7A5 (0.39) NPY4RNPY1RNPY5RNPY2RSLC7A5
Glycine SCHEMBL5579222 0.83 ITGB3 (0.45) NPY4RNPY1RNPY5RNPY2RSLC7A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0278781-B1 Peptides with laminin activity US COMMERCE (US) 1993-11-03 EP disclosed
WO-1988006039-A1 PEPTIDES WITH LAMININ ACTIVITY UNITED STATES OF AMERICA, REPRESENTED BY THE UNITE (US) 1988-08-25 WO disclosed
EP-0278781-A2 Peptides with laminin activity THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce (US) 1988-08-17 EP disclosed